Literature DB >> 21461922

GluR1 phosphorylation and persistent expression of levodopa-induced motor response alterations in the Hemi-Parkinsonian rat.

Maowen Ba1, Min Kong, Guoping Yu, Xuwen Sun, Zhuli Liu, Xiaotong Wang.   

Abstract

The phosphorylation of glutamate receptor 1 (GluR1) has been increasingly implicated in the formation and maintenance of plastic responses. To investigate molecular mechanisms that underlie the persisting alterations in motor response occurring with levodopa treatment of parkinsonian patients, we evaluated the time course of these changes in relation to the phosphorylation of GluR1 in 6-hydroxydopamine (6-OHDA) lesioned animals. Three weeks of twice-daily levodopa administration to rats shortened the duration of the rotational responses and increased the peak turning responses, which lasted at least 7 days after withdrawal of chronic levodopa treatment. The shortened response duration and increased peak turning, resembling human wearing-off fluctuations and dyskinesia, were associated with a marked increase in Ser-845 phosphorylated GluR1 (pGluR1S845) immunoreactivity in lesioned striatum in response to levodopa treatment. The time course of changes in GluR1 phosphorylation correlated with the time course of changes in motor behavior after withdrawal of chronic levodopa therapy. Our immunostaining data showed that these changes were confined to parvalbumin-positive neurons where GluR1 are exclusively expressed. Both the altered motor response and the degree of pGluR1S845 were attenuated by the intrastriatal administration of protein kinase A (PKA) inhibitor Rp-cAMPS or GluR1 antisense oligonucleotides. The results suggest that Ser-845 GluR1 phosphorylation within parvalbumin-positive neurons contributes to the persistence of the motor response alterations produced by chronic intermittent dopaminergic stimulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21461922     DOI: 10.1007/s11064-011-0461-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  "Ottorino Rossi" Award 2000. New targets for therapy in Parkinson's disease: pathogenesis and pathophysiology.

Authors:  J T Greenamyre
Journal:  Funct Neurol       Date:  2000 Apr-Jun

2.  Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory.

Authors:  Hey-Kyoung Lee; Kogo Takamiya; Jung-Soo Han; Hengye Man; Chong-Hyun Kim; Gavin Rumbaugh; Sandy Yu; Lin Ding; Chun He; Ronald S Petralia; Robert J Wenthold; Michela Gallagher; Richard L Huganir
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

3.  Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype.

Authors:  Alicia Rivera; Israel Alberti; Ana B Martín; José A Narváez; Adelaida de la Calle; Rosario Moratalla
Journal:  Eur J Neurosci       Date:  2002-12       Impact factor: 3.386

Review 4.  Dopamine/glutamate interactions in Parkinson's disease.

Authors:  K W Lange; J Kornhuber; P Riederer
Journal:  Neurosci Biobehav Rev       Date:  1997-07       Impact factor: 8.989

5.  Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.

Authors:  A W Dunah; D G Standaert
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

6.  Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats.

Authors:  C Marin; A Jimenez; M Bonastre; T N Chase; E Tolosa
Journal:  Synapse       Date:  2000-06-15       Impact factor: 2.562

7.  Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

Authors:  M Lundblad; M Andersson; C Winkler; D Kirik; N Wierup; M Angela Cenci
Journal:  Eur J Neurosci       Date:  2002-01       Impact factor: 3.386

Review 8.  Molecular basis of levodopa-induced dyskinesias.

Authors:  F Calon; R Grondin; M Morissette; M Goulet; P J Blanchet; T Di Paolo; P J Bédard
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

9.  Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens.

Authors:  M J Miserendino; E J Nestler
Journal:  Brain Res       Date:  1995-03-20       Impact factor: 3.252

Review 10.  Pharmacotherapy for Parkinson's disease.

Authors:  Jack J Chen; David M Swope
Journal:  Pharmacotherapy       Date:  2007-12       Impact factor: 4.705

View more
  5 in total

Review 1.  Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Authors:  Clare Finlay; Susan Duty
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

Review 2.  Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease.

Authors:  Susan Duty
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

3.  Postsynaptic density protein 95-regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat models.

Authors:  Maowen Ba; Min Kong; Guozhao Ma
Journal:  Drug Des Devel Ther       Date:  2014-12-19       Impact factor: 4.162

4.  Intrastriatal injections of KN-93 ameliorates levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Authors:  Xinxin Yang; Na Wu; Lu Song; Zhenguo Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-19       Impact factor: 2.570

Review 5.  Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.

Authors:  Clare J Finlay; Susan Duty; Anthony C Vernon
Journal:  Front Neurol       Date:  2014-06-12       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.